Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cosmos HealthCOSM +8.36%29 Intrinsic Value: Projected FCF is $-2.20 as of Aug. 20, 2026. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.35 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 75 Medical Distribution companies, Cosmos Health ranks worse than 1333332% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-08-20), Cosmos Health's Intrinsic Value: Projected FCF is $-2.20. The stock price of Cosmos Health is $0.2126. Therefore, Cosmos Health's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.
The historical rank and industry rank for Cosmos Health's Intrinsic Value: Projected FCF or its related term are showing as below:
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Cosmos Health was 47.44. The lowest was 10.32. And the median was 20.44.
COSM's Price-to-Projected-FCF is not ranked *
in the Medical Distribution industry.
Industry Median: 0.88 * Ranked among companies with meaningful Price-to-Projected-FCF only.
Cosmos Health (NAS:COSM) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Cosmos Health's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
0.2126
/
-2.1969454947521
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health Intrinsic Value: Projected FCF Related Terms
Cosmos Health Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Cosmos Health's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cosmos Health Intrinsic Value: Projected FCF Chart
COSM vs HKPD, MEDS, SNYR: Intrinsic Value: Projected FCF Comparison
For the Medical Distribution subindustry, Cosmos Health's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health Price-to-Projected-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Cosmos Health's Price-to-Projected-FCF falls into.
Cosmos Health Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $-2.20 mean?
Cosmos Health (COSM) has a Intrinsic Value: Projected FCF of $-2.20 as of Aug. 20, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Cosmos Health and its competitors. Over the past decade, Cosmos Health's Intrinsic Value: Projected FCF has ranged from 10.32 to 47.44. According to the industry distribution chart, Cosmos Health ranks #999999 out of 75 companies in the Medical Distribution industry.
Is Cosmos Health's Intrinsic Value: Projected FCF too high?
Cosmos Health's current Intrinsic Value: Projected FCF is $-2.20. Over the past 10 years, this metric has ranged from a low of 10.32 to a high of 47.44. Based on the distribution chart, Cosmos Health ranks #999999 out of 75 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Intrinsic Value: Projected FCF compare to HKPD and MEDS?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #999999 out of 75 companies for Intrinsic Value: Projected FCF. This places Cosmos Health in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 0.88. Historically, Cosmos Health's own Intrinsic Value: Projected FCF has ranged from 10.32 to 47.44 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Medical Distribution company?
The median Intrinsic Value: Projected FCF among Medical Distribution companies is 0.88, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median Intrinsic Value: Projected FCF is 0.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current Intrinsic Value: Projected FCF is $-2.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.35, compared to a current price of $0.21 — trading 39.3% below its estimated fair value. The current Intrinsic Value: Projected FCF is $-2.20. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Cosmos Health (COSM), the current Intrinsic Value: Projected FCF is $-2.20 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.21 is trading 39.3% below its estimated GF Value™ of $0.35.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
Intrinsic Value: Projected FCF: $-2.20
GF Value™: $0.35 vs. price of $0.21 (39.3% below fair value)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
